Category: psoriasis

According to a new study, psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer when compared to those not on methotrexate.

According to a new study, psoriasis patients reported that application feel, non-staining quality and quick absorption were the most important factors in their preference of topical treatments and in ensuring treatment adherence.

According to a recent study, guselkumab does not increase cancer risk in psoriasis (PsO) patients compared to general and psoriasis populations.

According to a recent press release, risankizumab has been shown to be efficacious and safe in patients with plaque psoriasis who have a suboptimal response to IL-17A inhibitors.

According to a new study, there is no increased risk of infections in pediatric psoriasis (PsO) patients treated with ustekinumab compared to etanercept or methotrexate.

According to a new study, psoriasis patients are significantly more likely to experience migraines than those without psoriasis.

A new study has evaluated the worldwide prevalence of mental disorders such as depression, anxiety, and suicide in patients with psoriasis. 

According to a recent study, patients with comorbid psoriatic arthritis (PsA) have a slightly decreased treatment response to biologics for psoriasis (PsO) than those without PsA.

According to a recent study, most psoriasis patients view their comorbid obesity as unrelated to their skin condition.

According to a new study, smoking and obesity-related factors such as body mass index and waist and hip circumference, are linked to an increased risk of psoriasis.